Access cutting-edge oral precancer treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Access oral precancer specialists in Boston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related oral precancer treatment provided free
The goal of this study is to understand the safety, tolerability, and potential efficacy of an injected immune therapy called RP2 to treat oral precancer conditions and prevent progression to an oral cancer. The name of the study drug involved in this study is: -RP2 (a genetically modified live Herpes Simplex V-1 strain)
Sponsor: Glenn J. Hanna
Check if you qualify for this oral precancer clinical trial in Boston, MA
If you're searching for oral precancer treatment options in Boston, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced oral precancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.